GLP1R and obesity due to melanocortin 4 receptor deficiency: Emerging evidence suggests that semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), may offer a more comprehensive therapeutic approach for male infertility associated with diabetes and obesity.